Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Günter Eisele"'
Autor:
Fabian Wolpert, Caroline Happold, Guido Reifenberger, Ana-Maria Florea, René Deenen, Patrick Roth, Marian Christoph Neidert, Katrin Lamszus, Manfred Westphal, Michael Weller, Günter Eisele
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0139603 (2015)
Immunotherapy targeting glioblastoma initiating cells (GIC) is considered a promising strategy. However, GIC are prone to evade immune response and there is a need for potent adjuvants. IFN-β might enhance the immune response and here we define its
Externí odkaz:
https://doaj.org/article/53e824d657814141a7cb2206d37e9ad3
Autor:
Friederike Schmidt, Michael Weller, Johann Leban, Günter Eisele, Caroline Herrmann, Maria Kissel, Patrick Roth
Supplementary Data from SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f89c3e912b03b35c970f5afbec63483
https://doi.org/10.1158/1078-0432.22440580.v1
https://doi.org/10.1158/1078-0432.22440580.v1
Autor:
Friederike Schmidt, Michael Weller, Johann Leban, Günter Eisele, Caroline Herrmann, Maria Kissel, Patrick Roth
Purpose: Glioblastomas are among the most lethal neoplasms, with a median survival of Experimental Design: Different tumor cell lines were tested by crystal violet staining for sensitivity to SC68896, given alone or in combination with death ligands.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051f70e6337bc9a3686825ba225d8043
https://doi.org/10.1158/1078-0432.c.6517885
https://doi.org/10.1158/1078-0432.c.6517885
Autor:
Dorothee Gramatzki, Caroline Hertler, Michael Weller, Fabian Wolpert, Katharina Seystahl, Patrick Roth, Günter Eisele
Publikováno v:
Journal of neuro-oncology. 147(3)
Gliomas are primary brain tumors with a life-limiting course of disease, and the last weeks of life are often characterized by neurological deficits that affect communication and personality. End-of-life treatment in this patient group therefore requ
Autor:
Oliver Heese, Günter Eisele, Manfred Westphal, Michael Weller, Caroline Hertler, Katrin Conen, Fabienne Huber, Silvia Hofer, Ulrich Roelcke, Patrick Roth, Tobias Weiss
Publikováno v:
Neurooncol Pract
Background During the course of disease, most glioma patients learn that there is no cure for their tumor. It is therefore not uncommon for patients or caregivers to seek complementary and alternative medicine (CAM) treatments. Patterns of CAM use va
Autor:
Manfred Westphal, Caroline Hertler, Ulrich Roelcke, Patrick Roth, Tobias Weiss, Silvia Hofer, Oliver Heese, Günter Eisele, Michael Weller, Fabienne Huber, Katrin Conen
BACKGROUND: Patients suffering from brain tumors, as other cancer patients, may rely on additional support of complementary and alternative medicine (CAM) treatment during the course of disease. However, the assessment and documentation of CAM is not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74bee2b88947f37b8c69ad75707293c6
https://europepmc.org/articles/PMC6144053/
https://europepmc.org/articles/PMC6144053/
Autor:
Marian Christoph Neidert, Patrick Roth, Luca Regli, Konstantina Kapolou, Janet Kerstin Peper, Manfred Westphal, Stefan Stevanovic, Ana Marcu, Fabian Wolpert, Günter Eisele, Daniel J. Kowalewski, Michael Weller, Reinhard Henschler, Sophie S. Wang, Hans-Georg Rammensee, Lena Katharina Freudenmann, Juliane S. Walz, Manuela Silginer, Katrin Lamszus, Linus Backert
Publikováno v:
Acta neuropathologica. 135(6)
Glioblastoma is the most frequent malignant primary brain tumor. In a hierarchical tumor model, glioblastoma stem-like cells (GSC) play a major role in tumor initiation and maintenance as well as in therapy resistance and recurrence. Thus, targeting
Autor:
Roger Stupp, Silvia Hofer, Michael Weller, Antonios Valavanis, Günter Eisele, Patrick Roth, Tobias Weiss, Michaela Tonder, Katharina Seystahl
Publikováno v:
Acta Oncologica. 53:1436-1440
Autor:
Hesham Elhalawani, Massoud Houshmand, Evandro Leite de Souza, Christopher N. Parris, Ao Liu, Eiji Sunami, Toshiaki Tanaka, Hu Zhu, Fatemeh Ahmadipour, Hiroaki Nozawa, Robin I. Taleb, Adriano Zangrandi, Yusuke Shinoda, Helena Tainá D. Silva, Satz Mengensatzproduktion, Alexander Tuan Falk, Yuejun Liu, Wanlong Zhou, Takeshi Nishikawa, Aline Guillot, Depei Wu, Rami Archid, Inmaculada Alés-Díaz, Eleni Nioti, Ioannis Starakis, Patrizia Mordenti, Michaela Tonder, Jürgen Weinreich, Patrizia Farina, Takeshi Hisada, Anastasia Kostaki, Anita Nasrallah, Noriaki Sunaga, Nicolas Magné, Elpis Mantadakis, Anita Hack, Suellen Maria P. Menezes-Silva, Isis Caroline da Silva Cirino, Masanobu Yamada, Costantine F. Daher, Hironori Yamaguchi, Patrick Roth, Perla Zgheib, Masahiko Motegi, Junichiro Tanaka, Hideomi Yamashita, Sofia Maraki, Michael Weller, Kyoichi Kaira, Vittorina Zagonel, Druckerei Stückle, Alfred Königsrainer, Luigi Cavanna, Behnam Kamalidehghan, Akira Honda, Yaoyao Shen, Hirotaka Kawano, Olivier Collard, Cécile Pacaut, Omar Abdel-Rahman, Toshiaki Watanabe, Hisao Imai, Shinsuke Kazama, Guillaume Moriceau, Kazushige Kawai, José P. Siqueira-Júnior, Giuseppe Lombardi, Shiwei Sun, Mineo Kurokawa, Elena Orlandi, Goh Yong Meng, Jane-Chloé Trone, Günter Eisele, Piers N. Plowman, Ana Maria Galeote-Miguel, Jia Chen, Khaled Bajaeifer, Alessandra Ferro, Tomomichi Kiyomatsu, George Samonis, Angelos Koutras, Ichiro Naruse, Hui Li, Mirvat El-Sibai, Sheba Adam-Zahir, Takashi Toya, Benoite Méry, Joji Kitayama, Tetsuo Ushiku, Yasunori Kogure, Keisuke Hata, Fable Zustovich, Yasuhito Nannya, Gema Durán-Ogalla, Mohamad Mroueh, Soichiro Ishihara, Manuel Benavides-Orgaz, Luis Enrique Rodelo-Haad, Akihide Yoshimi, Minas Sakellakis, Fariha Sharif, Reyhaneh Shakibi, Takayuki Asao, Haruki Kume, Timm C. Schott, Maria José Bermejo-Pérez, Emma C. Bourton
Publikováno v:
Chemotherapy. 60:I-IV
Publikováno v:
Neuro-Oncology. 16:382-391
BackgroundThere are emerging reports that the family of a disintegrin and metalloproteinases (ADAM) are involved in the maintenance of the malignant phenotype of glioblastomas. Notably, ADAM proteases 10 and 17 might impair the immune recognition of